**Clinical Summary for Patient Bauch723 Antonietta855**

**Patient Information:**
- **Name:** Bauch723 Antonietta855
- **Gender:** Female
- **Date of Birth:** December 14, 1980
- **Address:** 478 Abbott Green, Harrodsburg, KY 40330

**Medical History:**
- Served in armed forces (1999)
- Received higher education
- Miscarriage in the first trimester (1999)
- Social isolation (2007)
- Essential hypertension, prediabetes, and obesity (2014)
- Medication: Etonogestrel 68 MG Drug Implant (2012-present)
- Normal pregnancy (2015)
- Viral sinusitis (2015, 2017, 2018)
- Metabolic syndrome X (2016)
- Generalized anxiety disorder (Ongoing)
- Medication: Mirena 52 MG Intrauterine System (2018-present)

**Current Clinical Status (As of March 26, 2023):**
- Blood pressure: 72/100 mm[Hg]
- Heart rate: 61 /min
- Respiratory rate: 14 /min
- Glucose: 67.5 mg/dL
- BMI: 28.96 kg/m2
- Hemoglobin A1c: 5.82%
- Generalized Anxiety Disorder 7 item (GAD-7) total score: 12
- Total score on the Humiliation, Afraid, Rape, and Kick questionnaire (HARK): 0
- Total score on the Drug Abuse Screening Test-10 (DAST-10): 2

**Recommendations:**
1. **Medication Review:** Due to the patient's history of stress, generalized anxiety disorder, and elevated GAD-7 scores, a comprehensive medication review is recommended to reassess the effectiveness of current medications.
  
2. **Consultation with Mental Health Specialist:** Given the persistent anxiety symptoms (GAD-7 score of 12), a referral to a mental health specialist for further evaluation and potential adjustment of therapy is advised.

3. **Cardiovascular Risk Management:** Considering the patient's history of essential hypertension, prediabetes, and obesity, ongoing monitoring of cardiovascular risk factors is essential. Lifestyle modifications, including diet and exercise, should be discussed, and pharmacological interventions may be considered based on the overall risk profile.

4. **Obstetric and Gynecological Care:** Continue regular follow-ups related to the Mirena 52 MG Intrauterine System and discuss family planning options, especially if the patient expresses any concerns or changes in reproductive goals.

5. **Social Support and Stress Management:** Given the history of social isolation and stress, encourage the patient to engage in social activities and adopt stress management techniques. Support groups or counseling may be beneficial.

6. **Follow-up Imaging or Tests:** Regular monitoring of blood pressure, BMI, and glucose levels is crucial. Periodic imaging or lab tests may be needed to assess the long-term impact of medications and overall health.

**Immunizations:**
- Influenza, seasonal, injectable, preservative-free (Up to date)
- Hep A, adult (Up to date)
- Td (adult), 5 Lf tetanus toxoid, preservative-free, adsorbed (Up to date)

This summary aims to provide an overview of the patient's medical history, current clinical status, and actionable recommendations for ongoing care. Coordination with a multidisciplinary team, including primary care, mental health, and obstetric/gynecologic specialists, is advised for comprehensive and integrated care. Regular follow-ups and patient education are essential components of the management plan.